- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06668870
Electronic Health Record-Integrated Patient-Generated Data
March 27, 2026 updated by: Wake Forest University Health Sciences
Electronic Health Record-Integrated Patient-Generated Data to Support Clinical Care and Research
The purpose of this study is to find out if patients that receive supportive messaging with response adaptation are more likely to adhere to patient-generated data collection and electronic health record integration, compared to patients that do not receive supportive messaging.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This project will directly inform re-usable strategies to support the integration of important patient-generated data (PGD) into the electronic health record to improve clinical care and research.
For this application, investigators propose to develop and test the PGD translational science innovation in patients recovering from sepsis.
This diverse patient population frequently suffers from long-term complications that are ideally suited for development and demonstration of strategies to collect, integrate, and examine PGD and builds directly on the study team's robust research portfolio on improving sepsis recovery.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Discharged alive from the hospital without hospice care who meet clinical criteria for infection and organ dysfunction consistent with sepsis
- Enrolled into the Sepsis Transition and Recovery program
- Enrolled or willing to enroll as an Epic MyChart user
Exclusion Criteria:
- Discharged from the hospital with hospice care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supportive Messaging
Supportive messaging is a behavioral intervention delivered to motivate patients to engage with targeted patient-generated data collection tools.
Participants will be asked to complete patient-generated data.
At baseline, all patients will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information.
At baseline and regular intervals throughout follow up, the supportive messaging arm will receive added text messaging to engage patients and deliver personalized reminders to complete monitoring tasks.
|
Will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information.
Supplemental text messages will be sent to engage patients and deliver personalized reminders to complete monitoring tasks.
|
|
Active Comparator: No Supportive Messaging
Participants will be asked to complete patient-generated data.
At baseline, participants will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information.
Participants will not receive added text messaging to engage patients and deliver personalized reminders to complete monitoring tasks.
|
Will receive education about the collection of patient-generated data, training in using the data collection tools, and guidance on the standard frequency for collection and sharing of information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Completed Versus Requested Patient-Generated Data
Time Frame: 90 days post hospital discharge
|
Patient generated data completion defined as the proportion of completed vs requested patient generated data elements.
|
90 days post hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Readmissions
Time Frame: 90 days post hospital discharge
|
Number of readmissions to inpatient or observation status due to any cause assessed via electronic health record.
|
90 days post hospital discharge
|
|
Number of Deaths
Time Frame: 90 days post hospital discharge
|
Number of participant deaths due to any cause, assessed via electronic health record and national data sources integrated in the enterprise data warehouse.
|
90 days post hospital discharge
|
|
Number of Emergency Department Visits
Time Frame: 90 days post hospital discharge
|
Number of Emergency Department visits assessed via electronic health record.
|
90 days post hospital discharge
|
|
Number of Outpatient Clinic Visits
Time Frame: 90 days post hospital discharge
|
Number of outpatient clinic visits assessed via electronic health record
|
90 days post hospital discharge
|
|
Number of Hospital-Free Days
Time Frame: 90 days post hospital discharge
|
Number of hospital-free days calculated by total of days alive minus days hospitalized, measured from electronic health record data.
|
90 days post hospital discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marc Kowalkowski, PhD, Atrium Health Wake Forest Baptist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
October 28, 2024
First Submitted That Met QC Criteria
October 28, 2024
First Posted (Actual)
November 1, 2024
Study Record Updates
Last Update Posted (Actual)
April 2, 2026
Last Update Submitted That Met QC Criteria
March 27, 2026
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Systemic Inflammatory Response Syndrome
- Inflammation
- Pathological Conditions, Signs and Symptoms
- Sepsis
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Socioeconomic Factors
- Population Characteristics
- Records
- Medical Records
- Health Records, Personal
- Educational Status
- Patient Generated Health Data
Other Study ID Numbers
- IRB00113850
- 1UM1TR004929-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual participant data that underlie the results reported in this article, after deidentification will be shared (text, tables, figures, and appendices).
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
Will share with researchers who provide a methodologically sound proposal to assist in achieving aims in the approved proposal.
Proposals should be directed to ehale@wakehealth.edu.
To gain access, data requestors will need to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on Supplemental Text Messaging
-
University of Colorado, DenverNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedCOVID-19United States
-
University of Mississippi Medical CenterNot yet recruitingTobacco Cessation
-
University of RochesterCompleted
-
University of MichiganCompletedStroke | Hypertension
-
University of Nebraska LincolnThe Methodist Hospital Research InstituteCompletedDiabetes Mellitus, Type 2United States
-
China National Center for Cardiovascular DiseasesCompleted
-
University of MichiganCompletedStroke | HypertensionUnited States
-
The Miriam HospitalCompletedHIV | Adherence | RetentionUnited States